Twenty-four-hour profiles of plasma glucose, insulin, C-peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short-term, medium-dose prednisone (20 mg/day) treatment: Evidence for differing effects on insulin secretion and action

Clinical Endocrinology

Volumn 77, Issue 2, 2012, Pages 224-232

  Yuen, Kevin C J ^a   McDaniel, Patricia A ^a   Riddle, Matthew C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOCORTICOID; INSULIN; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES;

EID: 84863706204     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04242.x     Document Type: Article

References (34)

1. van Staa, T.P., Leufkens, H.G., Abenhaim, L., et al. (2000) Use of oral corticosteroids in the United Kingdom. Quarterly Journal of Medicine, 93, 105-111.
2. Donihi, A.C., Raval, D., Saul, M., et al. (2006) Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocrine Practice, 12, 358-362.
3. Gulliford, M.C., Charlton, J., &, Latinovic, R., (2006) Risk of diabetes associated with prescribed glucocorticoids in a large population. Diabetes Care, 29, 2728-2729.
4. van Raalte, D.H., Brands, M., van der Zijl, N.J., et al. (2011) Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial. Diabetologia, 54, 2103-2112.
5. Besse, C., Nicod, N., &, Tappy, L., (2005) Changes in insulin secretion and glucose metabolism induced by dexamethasone in lean and obese females. Obesity Research, 13, 306-311.
6. Pagano, G., Cavallo-Perin, P., Cassader, M., et al. (1983) An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. Journal of Clinical Investigation, 72, 1814-1820.
7. Subramanian, S., DeRosa, M.A., Bernal-Mizrachi, C., et al. (2006) PPARalpha activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans. American Journal of Physiology Endocrinology Metabolism, 291, E1365-E1371.
8. Lambillotte, C., Gilon, P., &, Henquin, J.C., (1997) Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. Journal of Clinical Investigation, 99, 414-423.
9. Longano, C.A., &, Fletcher, H.P., (1983) Insulin release after acute hydrocortisone treatment in mice. Metabolism, 32, 603-608.
10. Kalhan, S.C., &, Adam, P.A., (1975) Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration. Journal of Clinical Endocrinology and Metabolism, 41, 600-610.
11. van Raalte, D.H., Nofrate, V., Bunck, M.C., et al. (2010) Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. European Journal of Endocrinology, 162, 729-735.
12. Grill, V., Pigon, J., Hartling, S.G., et al. (1990) Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders. Metabolism, 39, 251-258.
13. Larsson, H., &, Ahren, B., (1999) Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity. Diabetologia, 42, 936-943.
14. Wajngot, A., Giacca, A., Grill, V., et al. (1992) The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders. Proceedings of the National Academy of Sciences of the United States of America, 89, 6035-6039.
15. American Diabetes Association. (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care, 34 (Suppl 1), S62-S69.
16. Wiedmeyer, H.M., Polonsky, K.S., Myers, G.L., et al. (2007) International comparison of C-peptide measurements. Clinical Chemistry, 53, 784-787.
17. Meyer, K.A., Conigrave, K.M., Chu, N.F., et al. (2003) Alcohol consumption patterns and HbA1c, C-peptide and insulin concentrations in men. Journal of the American College of Nutrition, 22, 185-194.
18. Cole, R.A., Soeldner, J.S., Dunn, P.J., et al. (1978) A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. Metabolism, 27, 289-301.
19. Davis, J.E., McDonald, J.M., &, Jarett, L., (1978) A high-performance liquid chromatography method for hemoglobin A1c. Diabetes, 27, 102-107.
20. Burt, M.G., Roberts, G.W., Aguilar-Loza, N.R., et al. (2011) Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. Journal of Clinical Endocrinology and Metabolism, 96, 1789-1796.
21. Clore, J.N., &, Thurby-Hay, L., (2009) Glucocorticoid-induced hyperglycemia. Endocrine Practice, 15, 469-474.
22. Kautzky-Willer, A., Thomaseth, K., Clodi, M., et al. (1996) Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism, 45, 486-491.
23. Meier, J.J., Veldhuis, J.D., &, Butler, P.C., (2005) Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. Diabetes, 54, 1649-1656.
24. Bruno, A., Carucci, P., Cassader, M., et al. (1994) Serum glucose, insulin and C-peptide response to oral glucose after intravenous administration of hydrocortisone and methylprednisolone in man. European Journal of Clinical Pharmacology, 46, 411-415.
25. Polonsky, K., Jaspan, J., Pugh, W., et al. (1983) Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. Journal of Clinical Investigation, 72, 1114-1123.
26. Magee, M.H., Blum, R.A., Lates, C.D., et al. (2001) Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. Journal of Clinical Pharmacology, 41, 1180-1194.
27. Buren, J., Lai, Y.C., Lundgren, M., et al. (2008) Insulin action and signalling in fat and muscle from dexamethasone-treated rats. Archives of Biochemistry and Biophysics, 474, 91-101.
28. Nicod, N., Giusti, V., Besse, C., et al. (2003) Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers. Obesity Research, 11, 625-631.
29. Fischer, B., Rausch, U., Wollny, P., et al. (1990) Immunohistochemical localization of the glucocorticoid receptor in pancreatic beta-cells of the rat. Endocrinology, 126, 2635-2641.
30. Matthes, H., Kaiser, A., Stier, U., et al. (1994) Glucocorticoid receptor gene expression in the exocrine and endocrine rat pancreas. Endocrinology, 135, 476-479.
31. Pagano, G., Bruno, A., Cavallo-Perin, P., et al. (1989) Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Archives of Internal Medicine, 149, 1098-1101.
32. Abdelmannan, D., Tahboub, R., Genuth, S., et al. (2010) Effect of dexamethasone on oral glucose tolerance in healthy adults. Endocrine Practice, 16, 770-777.
33. Bruno, A., Pagano, G., Benzi, L., et al. (1992) Change in glucose metabolism after long-term treatment with deflazacort and betamethasone. European Journal of Clinical Pharmacology, 43, 47-50.
34. van Raalte, D.H., Ouwens, D.M., &, Diamant, M., (2009) Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? European Journal of Clinical Investigation, 39, 81-93.